Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Total Current Liabilities: 2022-2025

Historic Total Current Liabilities for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Sep 2025 value amounting to $20.7 million.

  • Orchestra BioMed Holdings' Total Current Liabilities rose 27.36% to $20.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.7 million, marking a year-over-year increase of 27.36%. This contributed to the annual value of $16.2 million for FY2024, which is 44.60% up from last year.
  • As of Q3 2025, Orchestra BioMed Holdings' Total Current Liabilities stood at $20.7 million, which was up 21.07% from $17.1 million recorded in Q2 2025.
  • Over the past 5 years, Orchestra BioMed Holdings' Total Current Liabilities peaked at $21.5 million during Q3 2023, and registered a low of $306,538 during Q1 2022.
  • Moreover, its 3-year median value for Total Current Liabilities was $15.5 million (2025), whereas its average is $15.2 million.
  • The largest annual percentage gain for Orchestra BioMed Holdings' Total Current Liabilities in the last 5 years was 3,833.28% (2023), contrasted with its biggest fall of 39.63% (2023).
  • Orchestra BioMed Holdings' Total Current Liabilities (Quarterly) stood at $18.6 million in 2022, then slumped by 39.63% to $11.2 million in 2023, then soared by 44.60% to $16.2 million in 2024, then rose by 27.36% to $20.7 million in 2025.
  • Its Total Current Liabilities stands at $20.7 million for Q3 2025, versus $17.1 million for Q2 2025 and $15.5 million for Q1 2025.